China’s BeiGene expands collaboration with Novartis for oncology medicines
Drug Discovery | News | 0 Comment | 28 Dec, 2021
China-based BeiGene has announced an option, collaboration and license agreement with Novartis Pharma AG to develop, man...Read more
Merck and Ridgeback’s COVID-19 pill receives ‘special approval’ in Japan
Drug Discovery | News | 0 Comment | 27 Dec, 2021
Merck, known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics have announced that Japan’...Read more
Korea offers niclosamide-based drug as possible cure for COVID-19 variants
Drug Discovery | News | 0 Comment | 08 Dec, 2021
Experimental results have been published for the first time showing that an antiviral drug containing niclosamide, an an...Read more
Standigm, Institut Pasteur Korea team up for AI-based drug discovery research on TB
Drug Discovery | News | 0 Comment | 02 Dec, 2021
South Korea-based startup Standigm Inc. has announced the signing of a Memorandum of Understanding (MoU) with Institut P...Read more
Tackling onerousness drug development process through cost-effective genomic analysis platforms
Drug Discovery | Opinion | By Hithaishi C Bhaksar | 2 Comment | 02 Dec, 2021
The limitations of the existing drug discovery paradigm reveals that there are still no effective prevention or real cur...Read more
Holistic drug development strategy improves probability of success in oncology therapeutics
Drug Discovery | Opinion | By Hithaishi C Bhaksar | 2 Comment | 22 Nov, 2021
AUM Biosciences is a global clinical-stage biotech company, focused on discovering and developing novel target...Read more
Pfizer inks deal worth $5.29 B with US government for COVID-19 pill
Drug Discovery | News | 0 Comment | 19 Nov, 2021
Pfizer Inc. has announced an agreement with the US government to supply 10 million treatment courses of its investi...Read more
Pfizer seeks EUA for novel oral COVID-19 pill
Drug Discovery | News | 0 Comment | 17 Nov, 2021
Pfizer Inc. has announced that it is seeking Emergency Use Authorization (EUA) of its investigational oral antivira...Read more
Korea's GI Innovation inks MoU with Merck for bio drug development
Drug Discovery | News | 0 Comment | 10 Nov, 2021
South Korea-based GI Innovation has inked a biopharmaceutical manufacturing and development based Memorandum o...Read more
AUM Biosciences raises $27M “Series A” fund to advance precision cancer therapies
Drug Discovery | News | 0 Comment | 13 Oct, 2021
Singapore's AUM Biosciences (AUM) has completed of $27 million series A funding round to develop a drug pipeline focused...Read more
Israel's CytoReason introduces AI clinical drug development platform to Japan’s pharma market
Drug Discovery | News | 0 Comment | 30 Sep, 2021
CytoReason, an AI company developing computational disease models for discovery and clinical drug development, and Summi...Read more
Japan sets eyes on rare pediatric liver diseases
Drug Discovery | News | 0 Comment | 22 Sep, 2021
US-based Mirum Pharmaceuticals, Inc. and Japanese firm Takeda Pharmaceutical have entered into an exclusive licensing ag...Read more
Drug Discovery | News | 0 Comment | 17 Sep, 2021
SuperTrans Medical ("STM"), an Australian biopharmaceutical company developing novel antibiotics that target difficult-t...Read more
BC Platforms to enable longitudinal RWD and Genomics access for drug development in Africa
Drug Discovery | News | 0 Comment | 13 Sep, 2021
BC Platforms (BCP), a global leader in genomics research, analytics and global data access, announced a new collabo...Read more
French firm Poxel launches type 2 diabetes drug in Japan
Drug Discovery | News | 0 Comment | 10 Sep, 2021
French firm POXEL SA along with its partner, Sumitomo Dainippon Pharma, is launching TWYMEEG (Imeglimin hydro...Read more
Drug Discovery | Opinion | 4 Comment | 06 Sep, 2021
What unique initiatives are being taken by the company to connect microbiome with human health? Which are the major ther...Read more
Taiwan's Centre for Drug Evaluation initiates new drug trial against COVID-19
Drug Discovery | News | 1 Comment | 16 Aug, 2021
US-based Senhwa Biosciences, Inc. has announced that its novel oral drug, Silmitasertib, has been included in Taiwa...Read more
Healx’s AI-platform to create world’s most detailed rare disease biomedical knowledge graph
Drug Discovery | News | 1 Comment | 10 Aug, 2021
Healx, the AI-powered, UK-founded global drug discovery company, has entered a partnership with Japan's Ono Pharmace...Read more